SynBioBeta

Are you ready to join the ultimate gathering of bio geeks and changemakers? 🧪 SynBioBeta 2025 is where the synthetic biology community meets to share ideas, spark innovation, and build the future. Be part of the conversation—register today: https://loom.ly/gM9JE9M #SynBioBeta2025 #SyntheticBiology

Our founder and CEO, John Cumbers, rubbing elbows with UK Government officials and the Asst. Clk to the US Department of Awesome, Drew Endy. Spreading the Gospel of SynBio to our friends across the pond.

🚀 Only a week away! 🚀 The future of synthetic biology is accelerating—projected to grow from $19B in 2024 to $62B by 2029. This revolution is shaping healthcare, food, textiles, and beyond. Join SynBioBeta’s John Cumbers & Futurity Systems Mark Bünger for an exclusive live webinar where they’ll unveil key insights from the 2025 SynBioBeta Investor Report. 📅 Only one week left—register now for free to gain exclusive industry insights and early access to the full report! 🔗 register here: https://lnkd.in/gmKeHTjB #SynBio #Biotech #Innovation #Investment #FutureTech

Throwback to the Early Days of SynBioBeta In 2012, John Cumbers founded SynBioBeta, a network for biological engineers, innovators, and entrepreneurs. What started as a conference has grown into a global community shaping the future of synthetic biology. 12 years ago, John shared his vision in an interview about the rise of synthetic biology startups and the industry's shift from research to commercialization. Looking back, it’s incredible to see how far the field has come! Watch the interview from 12 years ago: https://lnkd.in/gQ7Yktuk #SyntheticBiology #SynBioBeta

Catch up on the latest news from SynBioBeta Digest: Following Your Nose Could Be the Key to Cartilage Repair Researchers at the University of Basel and University Hospital Basel are using nasal cells to grow superior cartilage grafts for knee repair. 🔗 https://lnkd.in/gsy33M-y Verinomics Unveils AI-Powered Platforms for Crop Breeding Verinomics’ Genesis™ and Genova™ platforms leverage AI for faster, transgene-free crop improvement. 🗣️ "We’re enabling rapid development of improved crop varieties," said Gio Scalzo, COO of Verinomics. 🔗 https://lnkd.in/gzE6uec5 NASA - National Aeronautics and Space Administration Study Explores Frozen Dunes for Clues to Life on Mars and Titan A $2.99M NASA-backed project, ARRKIS, studies microbial survival in Alaska’s Great Kobuk Sand Dunes. 🔗 https://lnkd.in/gweWJ53e ALA-CART: A Next-Gen Cancer Cure University of Colorado Anschutz Medical Campus researchers introduce ALA-CART, a CAR-T therapy upgrade to combat cancer resistance. 🗣️ "This optimizes CAR-T cells to better eliminate hidden cancer cells," said Cathy Pham-Danis, PhD. 🔗 https://lnkd.in/gCarHS7j Advancing Spinal Cord Injury Treatment Cellino and Matricelf team up to develop AI-powered, patient-specific regenerative therapies. 🔗 https://lnkd.in/g2M7twnB Sign up for SynBioBeta Digest: https://lnkd.in/gHrjvXx3

Join us for an exclusive Pre-Conference Attendee Zoom Call on March 26 at 8 AM PT! This is your chance to get insider details on the agenda, networking events, and must-see sessions, plus have all your questions answered before we kick off SynBioBeta 2025: The Global Synthetic Biology Conference in just six weeks. Register here: https://lnkd.in/gxK9r6np

Excited to Announce Dean Kamen at #SynBioBeta2025! "Every once in a while, a new technology, an old problem, and a big idea turn into an innovation." – Dean Kamen Dean Kamen, inventor, entrepreneur, and visionary. Known for revolutionizing industries from healthcare to robotics, Dean is the mind behind the Segway, LUKE robotic arm and HomeChoice™ dialysis machine. His groundbreaking work includes leading Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA in revolutionizing tissue and organ manufacturing, his relentless pursuit of innovation continues to tackle some of the world’s biggest challenges. At SynBioBeta 2025, Dean will share his insights on: - Cell Therapy & Manufacturing - Vaccine Innovation & Delivery - U.S. Investment in Science & Technology Dean’s journey reminds us that innovation is about more than technology—it’s about empathy, persistence, and the courage to think differently. As he says, "You get paid in life for the value you bring to the marketplace, not the hours you work." Don’t miss this chance to hear from a true pioneer who’s shaping the future of healthcare, STEM, and beyond. #DeanKamen

Galactic Gastronomy: The Science of Producing Food Beyond Earth What’s for dinner on the Moon? Maybe lab-grown meat, engineered spirulina, or AI-optimized crops. Forget freeze-dried ice cream—synthetic biology is opening entirely new frontiers for space food. As we prepare for the NASA - National Aeronautics and Space Administration Artemis missions to the Moon and eventually Mars, growing food off-planet isn’t just a novelty—it’s essential for sustainable, long-term exploration. In the latest SynBioBeta Insights article from Sachin Rawat, we learn how pioneers in synthetic biology are revolutionizing space nutrition. Adam Arkin (University of California, Berkeley) discusses gene-edited plants that can thrive in microgravity, while Lancia Lefebvre (AstroYeast) shares how engineered yeast could supply critical nutrients without extra chemical inducers. Yoav Reisler🎗️(Aleph Farms) shows how lab-grown meat offers fresh protein in orbit, and Barbara BELVISI (Interstellar Lab) details AI-controlled, closed-loop systems for resource-efficient farming in space. Read the full article here: https://lnkd.in/eD_XQcum These efforts aren’t just for the stars—they promise real benefits on Earth, too. By optimizing crops for cramped quarters and leveraging microbes to produce high-value ingredients, we can tackle resource constraints and improve agriculture everywhere. Explore the future of food beyond our planet and discover how space-farming innovations could reshape life at home. #SyntheticBiology #SpaceFood #Artemis #SpaceExploration #CellularAgriculture #FutureOfFood #AI #Sustainability #Mars #Moon

Cauldron Ferm CEO Michele Stansfield talks about their mission to realize the full potential of precision fermentation by unlocking price parity for mainstream bio-manufactured goods. #SyntheticBiology #SynBioBeta2024 #biotech

Bioeconomy & Biosecurity Sessions at #SynBioBeta2025 Explore the intersection of biosecurity, policy, and innovation as experts discuss the future of the U.S. bioeconomy, cutting-edge biosecurity technologies, and ethical considerations for biocontainment. 📅 Key Sessions: Securing the Future: Biosecurity Innovations in Synthetic Biology Industry leaders discuss advancements in biosecurity and risk mitigation strategies for emerging biotech. Featuring: Jake Beal ( RTX BBN Technologies), Becky Mackelprang (Engineering Biology Research Consortium), Dayal Saran (Allonnia), Natalio Krasnogor (GitLife Biotech), and James Diggans (Twist Bioscience). Sponsored by GitLife Biotech Future of the U.S. Bioeconomy How can policy, investment, and infrastructure drive the growth of the bioeconomy? Experts share insights on shaping the future of U.S. biotech. Featuring: Nazish Jeffery, Ph.D. (Federation of American Scientists), Sarah R. Carter, Ph.D. (Science Policy Consulting), Carrie Wolinetz (Lewis-Burke Associates LLC), Kerri Dugan (National Science Foundation (NSF)), and Sylvia Wulf, NACD. DC (Biotechnology Innovation Organization). Biology Without Borders: Technical & Ethical Considerations for Biocontainment Balancing innovation and responsibility—leading voices discuss technical and ethical challenges in biocontainment. Featuring: Becky Mackelprang (Engineering Biology Research Consortium), Steven Evans (BioMADE), Betty Lee (U.S. Dept. of Commerce), and Mary Maxon (Schmidt Sciences).